1
TÍTULO: Healthcare resource utilization and associated cost analysis of the PROCLAIM study in patients with stage III non-small-cell lung cancer
AUTORES: Ramaswamy Govindan; Suresh Senan; Nicolas Dickgreber; Mariano Provencio; Yi Long Wu; Konstantinos Syrigos; Barbara Parent; Michele Wilson; Ryan Ziemiecki; Nadia Chouaki; Anwar Hossai; Belk San Antonio; Katherine Winfree; Everett E Vokes;
PUBLICAÇÃO: 2019, FONTE: CURRENT MEDICAL RESEARCH AND OPINION, VOLUME: 35, NÚMERO: 10
INDEXADO EM: Scopus WOS
2
TÍTULO: Safety, Resource Use, and Quality of Life in PARAMOUNT A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer
AUTORES: Cesare Gridelli; Filippo de Marinis; Jean Louis Pujol; Martin Reck; Rodryg Ramlau; Barbara Parente; Thierry Pieters; Gary Middleton; Jesus Corral; Katherine Winfree; Symantha Melemed; Anna Zimmermann; William John; Julie Beyrer; Nadia Chouaki; Carla Visseren Grul; Luis G Paz Ares;
PUBLICAÇÃO: 2012, FONTE: JOURNAL OF THORACIC ONCOLOGY, VOLUME: 7, NÚMERO: 11
INDEXADO EM: Scopus WOS
3
TÍTULO: Phase II, Double-Blinded, Randomized Study of Enzastaurin Plus Pemetrexed as Second-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer
AUTORES: Alberto Chiappori; Gerold Bepler; Fabrice Barlesi; Jean Charles Soria; Martin Reck; Alessandra Bearz; Fernando Barata; Giorgio Scagliotti; Keunchil Park; Asavari Wagle; Astra M Liepa; Yan Daniel Zhao; Nadia Chouaki; Neill Iscoe; Joachim von Pawel;
PUBLICAÇÃO: 2010, FONTE: JOURNAL OF THORACIC ONCOLOGY, VOLUME: 5, NÚMERO: 3
INDEXADO EM: Scopus WOS CrossRef